Does SelectHealth Cover Lipitor?

How SelectHealth Formularies Classify Atorvastatin

SelectHealth, the insurance arm of Intermountain Health, maintains separate formularies for its commercial (employer-sponsored), Medicare Advantage, and ACA Marketplace plans. Generic atorvastatin appears on virtually all of these formularies at the lowest or second-lowest cost tier. Brand-name Lipitor lost U.S. patent exclusivity in November 2011, and generic versions now account for over 99% of atorvastatin prescriptions dispensed nationwide [1].

Because atorvastatin is one of the most widely prescribed medications in the United States, with over 89 million prescriptions dispensed in 2022 alone [2], insurers like SelectHealth face almost no cost barrier to covering the generic form. The wholesale acquisition cost for a 30-day supply of generic atorvastatin 20 mg sits below $4 at most distributors. That pricing reality is why SelectHealth places it on Tier 1 (preferred generic) in the majority of plan designs, meaning the lowest possible copay bracket.

For members enrolled in SelectHealth Medicare Advantage Part D plans, atorvastatin is classified as a Tier 1 generic under the standard CMS formulary framework. The Inflation Reduction Act's $2,000 annual Part D out-of-pocket cap, which took full effect in 2025, further limits total yearly spending on covered drugs, including atorvastatin [3]. SelectHealth Marketplace (ACA) plans must also follow federal essential health benefit mandates that require coverage of at least one drug in every pharmacological class, and statins are a required category [4].

Brand-name Lipitor, by contrast, is either excluded entirely from SelectHealth formularies or placed on a Tier 3 (non-preferred brand) level. Members who insist on the brand may face copays of $50 to $150 per fill, and SelectHealth can require the prescriber to submit a prior-authorization request demonstrating medical necessity for the brand over the generic.

What You Will Pay Out of Pocket

The exact copay depends on which SelectHealth product you carry. A 30-day supply of generic atorvastatin on a typical SelectHealth Advantage plan costs $0 to $10 at an in-network retail pharmacy. Commercial group plans often set the Tier 1 copay between $5 and $15.

Mail-order pharmacy programs through SelectHealth's preferred mail-order vendor can reduce per-unit costs further. A 90-day mail-order fill frequently costs twice the 30-day copay rather than three times, translating to a 33% discount per tablet for members who take atorvastatin long-term. Given that statin therapy is recommended as a lifelong intervention for most patients with established atherosclerotic cardiovascular disease (ASCVD) [5], the mail-order option represents meaningful savings over years of continuous use.

SelectHealth members with high-deductible health plans (HDHPs) paired with a health savings account (HSA) should note one important exception. Under the USPSTF Grade B recommendation for statin use in adults aged 40 to 75 who have at least one cardiovascular risk factor and a 10-year ASCVD risk of 10% or greater [6], ACA-compliant plans must cover the prescribed statin with $0 cost-sharing when it qualifies as preventive. This means that even on an HDHP, you may owe nothing for atorvastatin if your prescriber documents a qualifying indication. The IRS confirmed in Notice 2019-45 that HDHPs may cover preventive drugs pre-deductible without jeopardizing HSA eligibility.

Generic Atorvastatin vs. Brand Lipitor: Clinical Equivalence

The FDA requires every approved generic drug to demonstrate bioequivalence to its reference product, meaning the generic must deliver the same active ingredient at the same rate and extent of absorption [7]. Multiple bioequivalence studies submitted to the FDA confirmed that generic atorvastatin meets these standards. There is no clinically meaningful difference in LDL-C reduction between brand Lipitor and any FDA-approved generic atorvastatin.

The 2018 ACC/AHA Cholesterol Guideline explicitly states that "generic statins should be prescribed when available" because the clinical evidence base supporting statin benefit was built on the molecule itself, not the brand [5]. Dr. Scott Grundy, lead author of the 2018 guideline, noted: "High-intensity statin therapy remains the cornerstone of LDL-lowering treatment, and the generic forms of atorvastatin and rosuvastatin are the two primary options" [5].

Some patients report subjective differences when switching from brand to generic. A 2016 systematic review in the Annals of Internal Medicine (N = 2,258 across 7 RCTs) found no statistically significant difference in LDL-C lowering, adverse event rates, or discontinuation rates between brand and generic statins [8]. The nocebo effect, where negative expectations drive perceived side effects, accounted for most reported differences. If you experience new symptoms after switching, discuss them with your prescriber, but recognize that the active molecule is identical.

How to Confirm Your Specific SelectHealth Coverage

Plan designs change annually. The fastest way to verify your atorvastatin coverage:

1. Log in to selecthealth.org and manage to "Pharmacy Benefits" or "Drug Search."
2. Enter "atorvastatin" (not "Lipitor") to see the tier, copay, and any restrictions.
3. Check whether your plan uses a preferred pharmacy network; filling at a non-preferred pharmacy can double the copay.
4. Call the member services number on the back of your SelectHealth ID card for plan-specific details.

SelectHealth publishes its formulary documents in PDF format, typically updated at the start of each plan year (January 1 for commercial and Medicare Advantage; varies for Marketplace). Mid-year formulary changes are possible but require advance member notification as mandated by CMS and state insurance regulations [9].

If your prescriber writes for brand-name Lipitor and your plan does not cover it or requires step therapy through the generic first, you or your prescriber can submit a formulary exception request. SelectHealth's standard turnaround for non-urgent exception requests is 72 hours; urgent requests receive a 24-hour review under federal Part D and Marketplace timelines.

Prior Authorization and Step Therapy Rules

Generic atorvastatin almost never requires prior authorization on SelectHealth plans. The drug is too inexpensive and too broadly indicated for insurers to impose utilization management on the generic form. Step therapy, where the plan requires you to try a lower-cost drug before approving a more expensive one, is likewise not applied to first-line generic statins.

Prior authorization can enter the picture in two scenarios. First, if a prescriber requests brand-name Lipitor, SelectHealth may require documentation that the patient has a genuine medical reason for the brand, such as a confirmed allergy to an inactive ingredient in all available generic formulations. Second, if a prescriber wants to combine atorvastatin with a newer LDL-lowering agent like a PCSK9 inhibitor (evolocumab or alirocumab), that add-on therapy will almost certainly require prior authorization and evidence of inadequate LDL-C response on maximally tolerated statin therapy [10].

The 2022 ACC Expert Consensus Decision Pathway recommends considering PCSK9 inhibitors for patients with ASCVD whose LDL-C remains at or above 70 mg/dL on maximally tolerated statin therapy [11]. SelectHealth aligns its prior-authorization criteria for PCSK9 inhibitors with these guidelines, typically requiring documentation of LDL-C levels on at least 8 to 12 weeks of high-intensity statin therapy before approving the add-on.

SelectHealth Formulary Alternatives to Atorvastatin

If cost, side effects, or drug interactions make atorvastatin unsuitable, SelectHealth formularies list several other statins on preferred-generic tiers. Rosuvastatin (generic Crestor) offers similar high-intensity LDL-C reduction and sits on Tier 1 in most SelectHealth plans. The JUPITER trial (N = 17,802) demonstrated that rosuvastatin 20 mg reduced major cardiovascular events by 44% compared to placebo in patients with elevated high-sensitivity C-reactive protein [12].

Simvastatin and pravastatin are moderate-intensity options available at the lowest generic tier. Simvastatin carries a specific interaction warning with amlodipine (doses above 20 mg of simvastatin should not be combined with amlodipine), which the FDA addressed in a 2011 safety communication [13]. Pravastatin has fewer drug-drug interactions overall because it is not primarily metabolized by CYP3A4.

For patients who cannot tolerate any statin, SelectHealth may cover ezetimibe (generic Zetia) on a preferred-generic tier. Ezetimibe lowers LDL-C by approximately 18% to 20% as monotherapy [14]. The IMPROVE-IT trial (N = 18,144) showed that adding ezetimibe to simvastatin produced a statistically significant reduction in cardiovascular events over 7 years compared to simvastatin alone [14]. Bempedoic acid (Nexletol) is a newer non-statin LDL-C lowering drug; the CLEAR Outcomes trial (N = 13,970) demonstrated a 13% reduction in major adverse cardiovascular events in statin-intolerant patients [15]. Coverage for bempedoic acid on SelectHealth plans typically requires prior authorization.

Atorvastatin Dosing and What Your Prescriber May Order

Atorvastatin is available in 10 mg, 20 mg, 40 mg, and 80 mg tablets. The 2018 ACC/AHA guideline defines high-intensity statin therapy as atorvastatin 40 to 80 mg daily, which produces an expected LDL-C reduction of 50% or greater [5]. Moderate-intensity therapy (atorvastatin 10 to 20 mg) targets 30% to 49% LDL-C reduction.

All four strengths are priced identically in the generic market, so there is no cost penalty for higher doses on SelectHealth plans. Your copay for atorvastatin 80 mg is the same as for atorvastatin 10 mg.

The PROVE IT-TIMI 22 trial (N = 4,162) demonstrated that high-intensity atorvastatin 80 mg reduced the composite of death, MI, unstable angina, revascularization, and stroke by 16% compared to moderate-intensity pravastatin 40 mg in patients with acute coronary syndromes over a median of 24 months [16]. This trial was one of the key studies that established the "lower is better" principle for LDL-C management.

Dr. Christopher Cannon, the PROVE IT-TIMI 22 principal investigator, stated: "Intensive lipid lowering with atorvastatin 80 mg provided greater protection against death or major cardiovascular events than standard therapy. These results support treating to lower LDL cholesterol levels than those recommended at the time" [16].

How the ACA Preventive Coverage Rule Affects Your Statin Cost

This rule matters more than many patients realize. Under Section 2713 of the Affordable Care Act, non-grandfathered health plans must cover USPSTF Grade A and B recommended preventive services with zero cost-sharing [6]. The USPSTF issued a Grade B recommendation for statin use in adults aged 40 to 75 who have one or more cardiovascular risk factors (dyslipidemia, diabetes, hypertension, or smoking) and a calculated 10-year ASCVD risk of 10% or greater.

If you meet those criteria, your SelectHealth plan is required to cover atorvastatin (or another recommended statin) with no copay, no coinsurance, and no deductible applied. This applies even to high-deductible plans. The practical effect: millions of SelectHealth members are entitled to free atorvastatin but pay a copay because their pharmacy claim was not coded as preventive.

To ensure $0 cost-sharing, ask your prescriber to include the appropriate ICD-10 diagnosis code for primary prevention on the prescription. If your pharmacy charges a copay and you believe you qualify for preventive coverage, call SelectHealth member services and request a claim reprocessing under the preventive benefit.

SelectHealth Pharmacy Network and Preferred Pharmacies

SelectHealth contracts with a broad retail pharmacy network in Utah and surrounding states. Preferred pharmacies, which often include Intermountain Health system pharmacies, Smith's, and select independent pharmacies, offer the lowest copays. Non-preferred in-network pharmacies may charge a higher copay for the same generic atorvastatin.

Using a 90-day mail-order fill through SelectHealth's preferred mail-order pharmacy can drop the per-tablet cost further. For a medication like atorvastatin that requires indefinite use in most patients with ASCVD or significant risk factors, switching to mail order and automatic refills improves both adherence and cost efficiency.

A 2019 meta-analysis in the American Journal of Managed Care found that mail-order pharmacy use was associated with 2% to 5% higher medication adherence rates and lower total healthcare costs compared to retail pharmacy fills for chronic medications including statins [17]. Given that each 10% improvement in statin adherence is associated with a measurable reduction in cardiovascular events, the mail-order option carries clinical significance beyond simple convenience.